Top In Vitro Fertilization Companies

In Vitro Fertilization Market size was valued at USD 29.05 Billion in 2024 and is poised to grow from USD 31.49 Billion in 2025 to USD 60.04 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026–2033).

The key vendors in the In Vitro Fertilization Market include CooperSurgical, Inc., Vitrolife AB, Cook Medical, Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Irvine Scientific, Esco Medical, Hamilton Thorne Ltd., Genea Biomedx, and IVFtech ApS. These companies focus on advanced fertility treatments, embryo culture systems, reproductive laboratory equipment, and innovative technologies to improve IVF outcomes.

The key driver of the In Vitro Fertilization Market is the rising prevalence of infertility due to delayed parenthood, lifestyle changes, and reproductive health disorders. Growing awareness of assisted reproductive technologies, improved IVF success rates, and expanding access to fertility clinics further support market growth.

The key market trend in the In Vitro Fertilization Market is the growing adoption of advanced reproductive technologies, including AI-assisted embryo selection, genetic testing, and time-lapse embryo monitoring. These innovations improve treatment precision, support personalized fertility care, and enhance the potential for successful pregnancy outcomes.

North America accounted for the largest share of the In Vitro Fertilization Market, driven by advanced fertility care infrastructure, high awareness of assisted reproductive technologies, and growing infertility treatment demand. Favorable healthcare access, strong investments in reproductive medicine, and the presence of established fertility clinics further support regional market dominance.